Like many other companies and institutions around the world, we are experiencing interference with some of our systems within the TNT network.
We are implementing remediation steps as quickly as possible. We have implemented operational contingencies to continue to complete collections from customers with scheduled stops. For customers who do not have a regular stop, collection should be arranged via our customer service centers.
Customers may experience delays in the transit of shipments, particularly inter-continental or non-EU European delivery, as we work to remediate our systems. Additionally, if customers do not have the facility for self-labeling, they may also experience delays.
We are not able to collect shipments of dangerous goods at this time.
We regret any inconvenience to our customers.
Utilising our State-of-the-art Containment Technology
We have designed, manufactured and installed state-of-the-art containment technology to facilitate the processing of potent compounds in both our non-GMP and GMP pharmaceutical development facilities. To contain airborne particulates, we have applied engineering solutions that employ rigid and flexible film isolator technology around the processing zones of equipment. Extensive dust monitoring exercises have determined the effectiveness of these containment solutions, demonstrating that we can process compounds with an OEL as low as 50ng per m3.
We have the capability to process potent compounds using a wide variety of processing techniques, which include:
- Dry granulation
- Wet granulation / fluid bed drying
- Tablet coating